What the evidence says. Graded mixed: meta-analyses confirm BCAAs reduce post-exercise soreness and creatine kinase, but controlled isotope studies show isolated BCAAs do NOT meaningfully build muscle — they stimulate protein synthesis far less than whey, and most people already get enough from food and protein supplements. (Mixed evidence: Conflicting results across studies; benefit uncertain.)
What is BCAAs?
BCAAs (Branched-Chain Amino Acids) is a performance supplement used for reduce muscle soreness (doms). NutriDex grades the human evidence as Mixed. BCAAs are three essential amino acids — leucine, isoleucine and valine — sold for muscle growth, recovery and reduced fatigue. The evidence is genuinely split. Meta-analyses show BCAA supplementation meaningfully lowers delayed-onset muscle soreness (effect size ~0.7) and the muscle-damage marker creatine kinase, but has no effect on lactate dehydrogenase or actual exercise performance. Crucially, controlled tracer studies show that taking BCAAs alone raises muscle protein synthesis only ~22% — roughly half the response to an equivalent dose of whey — because building muscle requires all nine essential amino acids, not just three. A leading review concluded the claim that dietary BCAAs alone are anabolic is 'unwarranted.' In cirrhosis, BCAAs do improve hepatic encephalopathy symptoms (Cochrane), though without lowering mortality. For most well-fed people eating enough protein, BCAAs add little over food or whey.
Purported Benefits
✓Reduce muscle soreness (DOMS)
✓Lower creatine kinase after exercise
✓Support liver disease (HE symptoms)
✓May blunt training fatigue
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
Commonly 5–20 g/day (often 2:1:1 leucine:isoleucine:valine), taken around training; effects are modest and a complete protein usually does the job better.
Active Compounds
L-LeucineL-IsoleucineL-Valine
Safety & Cautions
⚠
BCAAs are generally well tolerated and recognized as safe at typical doses; high intakes can cause nausea, GI upset or fatigue. Observational data link high circulating BCAA levels to insulin resistance and type 2 diabetes risk, though this likely reflects impaired metabolism rather than harm from supplements — caution and glucose monitoring are still reasonable in diabetes. Because BCAAs compete with other amino acids for transport, they may theoretically reduce absorption of L-DOPA (levodopa) in Parkinson's disease; people on protein-restricted diets, with maple syrup urine disease, or with advanced kidney disease should avoid them without medical advice. Educational only — always check with your doctor or pharmacist before combining BCAAs with any medicine.
BCAAs is most often taken for Reduce muscle soreness (DOMS), Lower creatine kinase after exercise, Support liver disease (HE symptoms), May blunt training fatigue. Leucine, isoleucine & valine — popular for recovery, but not muscle-building on their own.
Does BCAAs work — what does the evidence say?
Mixed evidence. Conflicting results across studies; benefit uncertain. BCAAs are three essential amino acids — leucine, isoleucine and valine — sold for muscle growth, recovery and reduced fatigue. The evidence is genuinely split. Meta-analyses show BCAA supplementation meaningfully lowers delayed-onset muscle soreness (effect size ~0.7) and the muscle-damage marker creatine kinase, but has no effect on lactate dehydrogenase or actual exercise performance. Crucially, controlled tracer studies show that taking BCAAs alone raises muscle protein synthesis only ~22% — roughly half the response to an equivalent dose of whey — because building muscle requires all nine essential amino acids, not just three. A leading review concluded the claim that dietary BCAAs alone are anabolic is 'unwarranted.' In cirrhosis, BCAAs do improve hepatic encephalopathy symptoms (Cochrane), though without lowering mortality. For most well-fed people eating enough protein, BCAAs add little over food or whey.
What is the typical dose of BCAAs?
Commonly 5–20 g/day (often 2:1:1 leucine:isoleucine:valine), taken around training; effects are modest and a complete protein usually does the job better.
Is BCAAs safe? Any cautions or side effects?
BCAAs are generally well tolerated and recognized as safe at typical doses; high intakes can cause nausea, GI upset or fatigue. Observational data link high circulating BCAA levels to insulin resistance and type 2 diabetes risk, though this likely reflects impaired metabolism rather than harm from supplements — caution and glucose monitoring are still reasonable in diabetes. Because BCAAs compete with other amino acids for transport, they may theoretically reduce absorption of L-DOPA (levodopa) in Parkinson's disease; people on protein-restricted diets, with maple syrup urine disease, or with advanced kidney disease should avoid them without medical advice.
How many studies support BCAAs?
NutriDex cites 9 sources for BCAAs, graded "Mixed".
Cite this page
APA
Peh, D. (2026). BCAAs (Branched-Chain Amino Acids): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 16 Sept 2026, from https://nutridex.info/s/bcaa
BibTeX
@misc{nutridex_bcaa,
author = {Peh, Daryl},
title = {BCAAs (Branched-Chain Amino Acids): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/bcaa},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-09-16}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.